Major players in the global food and beverage industry are apprehensively waiting for the World Health Organization's (WHO) impending declaration of aspartame as a possible carcinogen. This widely-used artificial sweetener is a key ingredient in numerous diet drinks, yogurt drinks, and sugar-free gums.
The Korea Times reported that in South Korea, officials said on Sunday, June 2, that the International Agency for Research on Cancer (IARC), which is operating under WHO, is set to classify the said sweetener as "possibly carcinogenic to humans."
It was mentioned that aspartame is one of the most popular substitutes to sweeten foods and beverages without adding sugar. It is commonly used in Diet Coke, Diet Snapple, yogurt drinks, chewing gums, and makgeolli in South Korea.
Moreover, in the local market, Pepsi Zero, which Lotte Chilsung Beverage is distributing, also has aspartame as an ingredient. The company has been importing this soda drink directly from PepsiCo's main office in New York and only bottles them in Korea.
"Aspartame has been used by F&B companies around the world for a long time. It is not an issue of an individual company but rather that of the whole related industry, globally. We are currently discussing the matter with the Ministry of Food and Drug Safety (MFDS) and will wait to see what they have to say," an official at Lotte Chilsung Beverage said in a statement.
If aspartame is classified as a carcinogen, Lotte will suffer great economic damage since sales of Pepsi Zero is likely to drop with the news. Fortune reported that WHO is set to officially announce the results of its evaluations starting on July 14.
Finally, WHO initially said that there is still limited evidence that links aspartame to cancer, and it is the lowest of three categories which are "probable carcinogen" and "carcinogenic to humans."
Photo by: Alexander Grey/Unsplash


UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
US Dollar Dips as Iran Rejects Ceasefire Amid Rising Middle East Tensions
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
U.S.-China Trade Talks: Trump and Xi Set for Summit Amid Rare Earths Focus
Sterling Slides as Dollar Holds Firm Amid U.S.-Iran Tensions
Trump Suspends Iran Strikes for Two Weeks as Ceasefire Talks Begin
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Asian Currencies Rally as Dollar Weakens, Trump-Iran Ceasefire Boosts Risk Sentiment
Oil Prices Crash 15% as Trump and Iran Agree to Two-Week Ceasefire
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
First Western Ship Transits Strait of Hormuz Since Iran War Began
Britain Courts Anthropic Amid US Defense Department Dispute
Gold Prices Drop for Third Consecutive Session Amid Iran Tensions and Inflation Fears
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Oil Prices Crash Nearly 15% After Trump-Iran Ceasefire Deal 



